Cite

HARVARD Citation

    Peters, P. et al. (n.d.). 94 Comparative benefit of olaparib in recurrent BRCAm ovarian, breast, pancreatic and prostate cancer. International journal of gynecological cancer. p. A47. [Online]. 
  
Back to record